These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1096 related articles for article (PubMed ID: 32081779)

  • 61. Comparison of conventional chemotherapy, stealth liposomes and temperature-sensitive liposomes in a mathematical model.
    Gasselhuber A; Dreher MR; Rattay F; Wood BJ; Haemmerich D
    PLoS One; 2012; 7(10):e47453. PubMed ID: 23082168
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pharmacokinetics and pharmacodynamics evaluation of a thermosensitive chitosan based hydrogel containing liposomal doxorubicin.
    Ren S; Dai Y; Li C; Qiu Z; Wang X; Tian F; Zhou S; Liu Q; Xing H; Lu Y; Chen X; Li N
    Eur J Pharm Sci; 2016 Sep; 92():137-45. PubMed ID: 27388491
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Lactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomas.
    Chen H; Qin Y; Zhang Q; Jiang W; Tang L; Liu J; He Q
    Eur J Pharm Sci; 2011 Sep; 44(1-2):164-73. PubMed ID: 21782939
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Molecular and pharmacokinetic properties associated with the therapeutics of bcl-2 antisense oligonucleotide G3139 combined with free and liposomal doxorubicin.
    Lopes de Menezes DE; Hudon N; McIntosh N; Mayer LD
    Clin Cancer Res; 2000 Jul; 6(7):2891-902. PubMed ID: 10914739
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hybrid cell membranes camouflage liposomes containing payloads to improve breast cancer chemo and photodynamic therapy.
    Wang C; Wu S
    Biomater Sci; 2024 Sep; 12(19):4980-4992. PubMed ID: 39169828
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The impact of phospholipids with high transition temperature to enhance redox-sensitive liposomal doxorubicin efficacy in colon carcinoma model.
    Mirhadi E; Askarizadeh A; Farhoudi L; Mashreghi M; Behboodifar S; Alavizadeh SH; Arabi L; Jaafari MR
    Chem Phys Lipids; 2024 Jul; 261():105396. PubMed ID: 38621603
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Increased delivery of doxorubicin into tumor cells using extracellularly activated TAT functionalized liposomes: in vitro and in vivo study.
    Yuan W; Kuai R; Ran R; Fu L; Yang Y; Qin Y; Liu Y; Tang J; Fu H; Zhang Q; Yuan M; Zhang Z; Gao F; He Q
    J Biomed Nanotechnol; 2014 Aug; 10(8):1563-73. PubMed ID: 25016656
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Folate and TAT peptide co-modified liposomes exhibit receptor-dependent highly efficient intracellular transport of payload in vitro and in vivo.
    Zhu Y; Cheng L; Cheng L; Huang F; Hu Q; Li L; Tian C; Wei L; Chen D
    Pharm Res; 2014 Dec; 31(12):3289-303. PubMed ID: 24858397
    [TBL] [Abstract][Full Text] [Related]  

  • 69. pH-Sensitive, Long-Circulating Liposomes as an Alternative Tool to Deliver Doxorubicin into Tumors: a Feasibility Animal Study.
    Silva JO; Fernandes RS; Lopes SC; Cardoso VN; Leite EA; Cassali GD; Marzola MC; Rubello D; Oliveira MC; de Barros AL
    Mol Imaging Biol; 2016 Dec; 18(6):898-904. PubMed ID: 27172938
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A novel combination of TRAIL and doxorubicin enhances antitumor effect based on passive tumor-targeting of liposomes.
    Guo L; Fan L; Ren J; Pang Z; Ren Y; Li J; Wen Z; Jiang X
    Nanotechnology; 2011 Jul; 22(26):265105. PubMed ID: 21586819
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tumor targeting using anti-her2 immunoliposomes.
    Park JW; Kirpotin DB; Hong K; Shalaby R; Shao Y; Nielsen UB; Marks JD; Papahadjopoulos D; Benz CC
    J Control Release; 2001 Jul; 74(1-3):95-113. PubMed ID: 11489487
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Glycol Chitosan-Docosahexaenoic Acid Liposomes for Drug Delivery: Synergistic Effect of Doxorubicin-Rapamycin in Drug-Resistant Breast Cancer.
    Kim MW; Niidome T; Lee R
    Mar Drugs; 2019 Oct; 17(10):. PubMed ID: 31614820
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Doxorubicin-loaded micelles of amphiphilic diblock copolymer with pendant dendron improve antitumor efficacy: In vitro and in vivo studies.
    Voon SH; Kue CS; Imae T; Saw WS; Lee HB; Kiew LV; Chung LY; Yusa SI
    Int J Pharm; 2017 Dec; 534(1-2):136-143. PubMed ID: 29031979
    [TBL] [Abstract][Full Text] [Related]  

  • 74. High drug loading and pH-responsive targeted nanocarriers from alginate-modified SPIONs for anti-tumor chemotherapy.
    Peng N; Wu B; Wang L; He W; Ai Z; Zhang X; Wang Y; Fan L; Ye Q
    Biomater Sci; 2016 Nov; 4(12):1802-1813. PubMed ID: 27792228
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The co-delivery of a low-dose P-glycoprotein inhibitor with doxorubicin sterically stabilized liposomes against breast cancer with low P-glycoprotein expression.
    Gao W; Lin Z; Chen M; Yang X; Cui Z; Zhang X; Yuan L; Zhang Q
    Int J Nanomedicine; 2014; 9():3425-37. PubMed ID: 25092974
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A comparative study of polydopamine modified and conventional chemical synthesis method in doxorubicin liposomes form the aspect of tumor targeted therapy.
    Bi D; Zhao L; Li H; Guo Y; Wang X; Han M
    Int J Pharm; 2019 Mar; 559():76-85. PubMed ID: 30677481
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dual drug loaded liposome bearing apigenin and 5-Fluorouracil for synergistic therapeutic efficacy in colorectal cancer.
    Sen K; Banerjee S; Mandal M
    Colloids Surf B Biointerfaces; 2019 Aug; 180():9-22. PubMed ID: 31015105
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Liposomal doxorubicin loaded PLGA-PEG-PLGA based thermogel for sustained local drug delivery for the treatment of breast cancer.
    Cao D; Zhang X; Akabar MD; Luo Y; Wu H; Ke X; Ci T
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):181-191. PubMed ID: 30686051
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A Novel Diosgenin-Based Liposome Delivery System Combined with Doxorubicin for Liver Cancer Therapy.
    Chen L; Lan J; Li Z; Zeng R; Wang Y; Zhen L; Jin H; Ding Y; Zhang T
    Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015311
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Design principles of drug combinations for chemotherapy.
    Wu D; Pusuluri A; Vogus D; Krishnan V; Shields CW; Kim J; Razmi A; Mitragotri S
    J Control Release; 2020 Jul; 323():36-46. PubMed ID: 32283210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.